Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

CellDx-Tissue

K-Number: K260235 · 2026-05-12

Decision Date2026-05-12
Product CodePZM
Advisory CommitteePA
DecisionSubstantially Equivalent

Device Summary

CellDx-Tissue is a medical device manufactured by Datar Cancer Genetics Private Limited. It received FDA 510(k) clearance on 2026-05-12 under approval number K260235. The device is classified under product code PZM. It was reviewed by the PA advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the CellDx-Tissue?

CellDx-Tissue is a medical device that received FDA 510(k) clearance on 2026-05-12. It is manufactured by Datar Cancer Genetics Private Limited. The 510(k) number is K260235.

When was CellDx-Tissue approved by the FDA?

CellDx-Tissue received FDA 510(k) clearance on 2026-05-12, under approval number K260235.

What company makes CellDx-Tissue?

CellDx-Tissue is manufactured by Datar Cancer Genetics Private Limited.

What is the FDA product code for CellDx-Tissue?

The FDA product code for CellDx-Tissue is PZM.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.